Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trial

202286 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: Nature Medicine

Volume 28, Issue 5, pp. 1022-1030

Field-Weighted Citation Impact: 5.98